DXS have been back on my watch list over recent times. There is no question that they are a good solid company with a great diverse portfolio. I am however still sitting on the fence for the following reasons.
* Are there more write downs to come...so is the current NTA per share still inflated or is it going to get worse over the next few years?
* Will incentives to tenants continue to increase into 2024 and 25 as times become tougher and with a significant increase in leases expiring next year and the year after?
* Are companies going to downsize or rethink office and industrial space on the back of learnings from the past 3 years?
*So is the sector still going to be given a wider berth over the coming few years before things recover?
On the plus side is that Dexus has relatively low gearing and could find themselves with a ringside seat at possible upcoming distressed sales.
- Forums
- ASX - By Stock
- Ann: 2023 Annual Results Presentation
DXS
dexus
Add to My Watchlist
0.00%
!
$6.96

DXS have been back on my watch list over recent times. There is...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.96 |
Change
0.000(0.00%) |
Mkt cap ! $7.485B |
Open | High | Low | Value | Volume |
$6.97 | $6.99 | $6.93 | $11.43M | 1.643M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $6.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.97 | 39577 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 6.950 |
3 | 27256 | 6.940 |
3 | 3389 | 6.930 |
1 | 3712 | 6.910 |
6 | 5869 | 6.900 |
Price($) | Vol. | No. |
---|---|---|
6.970 | 39577 | 2 |
6.980 | 28984 | 4 |
7.000 | 2000 | 1 |
7.010 | 491 | 1 |
7.020 | 1890 | 2 |
Last trade - 16.12pm 04/07/2025 (20 minute delay) ? |
Featured News
DXS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online